References
- Tohyama C, Suzuki IS, Homma S, Karasawa M, Kuroki T, Nishimura H, et al. Testosterone-dependent induction of metallothionein in genital organs of male rats. Biochem J 1996; 317: 97–102.
- Cherian MG. The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ Health Perspect 1994; 102 (Suppl 3): 131–5.
- Kagi JHR. Overview of metallothionein. In: Riodan JF, Vallee BL, editors. Methods in enzymology 1991; 205. Metallobiochemistry, part B, Metallothionein and related molecules. San Diego: Academic Press.: 613–5.
- Manuel Y, Thomas Y, Pellegrini 0. Metallothionein and tissue damage. In: Nordberg GF, Herber RFM, Ales sio L, editors. Cadmium in the human environment: toxicity and carcinogenicity. Lyon: International Agency for Research on Cancer; 1992: 231–7.
- Luke MC, Coffey DS. The male sex accessory tissues. In: Knobil E, Neill JD, editors. The physiology of reproduction. New York: Raven Press; 1994: 1435–87.
- Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. C A 1996; 46: 5–27.
- Benson RC, Clark WR, Farrow GM. Carcinoma of the seminal vesicle. J Urol 1984; 132: 483–5.
- Dalgaard JB, Giertsen JC. Primary carcinoma of the seminal vesicle. Case and survey. Acta Path Microbiol Scand 1956; 39: 255–67.
- Ohmori T, Okada K, Sugiura K, Nabeshima S, Ohoka H, Okamoto M. CA 125-producing adenocarcinoma of the seminal vesicle. Pathol Int 1994; 44: 333–7.
- Stayner L, Smith R, Thun M, Schorr T, Lemen R. A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann Epidemiol 1992; 2: 177–94.
- Cherian MG, Howell SB, Imura N, Klaassen CD, Koropatnick J, Lazo JS, et al. Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol 1994; 126: 1–5.
- Elinder GC, KjellstrOm T, Hogstedt C, Andersson K, Spang G. Cancer mortality of cadmium workers. Br J Ind Med 1985; 42: 651–5.
- Kazantzis G, Blanks RG, Sullivan KR. Is cadmium a human carcinogen? In: Nordberg GF, Herber RFM, Alessio L, editors. Cadmium in the human environment: toxicity and carcinogenicity. Lyon: International Agency for Research on Cancer; 1992.
- Kolonel L, Winterstein Jr W. Cadmium and prostatic carcinoma. Lancet 1977; 10: 566–7.
- Lemen RA, Lee JS, Wagoner JK, Blejer HP. Cancer mortality among cadmium production workers. Ann NY Acad Sci 1976; 271: 273–9.
- Hoffmann L, Putzke HP, Bendel L, Erdmann T, Huckstorf C. Electron microscopic results on the ventral prostate of the rat after CdC12 administration. A contribution towards etiology of the cancer of the prostate. J Cancer Res Clin Oncol 1988; 114: 273–8.
- Waalkes MP, Donovan MP, Thomas JA. Cadmium-induced prostate metallothionein in the rabbit. Prostate 1982; 3: 23–5.
- Waalkes MP, Rehm S. Carcinogenicity of oral cadmium in the male Wistar (WF/NCr) rat: effect of chronic dietary zinc deficiency. Fundam Appl Toxicol 1992; 19: 512–20.
- Schroeder ll, Cousins RJ. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cell cultures. Proc Natl Acad Sci USA 1990; 87: 3137–41.
- Nagel WW, Vallee BL. Cell cycle regulation of metallothionein in human colonic cancer cells. Proc Natl Acad Sci USA 1995; 92: 579–83.
- Woo ES, Kondo Y, Watkins SC, Hoyt DG, Lazo JS. Nucleophilic distribution of metallothionein in human tumor cells. Exp Cell Res 1996; 224: 365–71.
- Oikawa S, Kurasaki M, Kojima Y, Kawanishi S. Oxidative and nonoxidative mechanisms of site-specific DNA cleavage induced by copper-containing metal-lothioneins. Biochemistry 1995; 34: 8763–70.
- Waalkes MP, Goering PL. Metallothionein and other cadmium binding proteins: recent developments. Chem Res Toxicol 1990; 3: 281–8.
- Oldereid NB, Thomassen Y, Attramadal A, Olaisen B, Purvis K. Concentrations of lead, cadmium and zinc in the tissues of reproductive organs of men. J Reprod Feral 1993; 99: 421–5.
- Suzuki T, Umeyama T, Ohma C, Yamanaka H, Suzuki K, Nakajima K, et al. Immunohistochemical study of metallothionein in normal and benign prostatic hyper-plasia of human prostate. Prostate 1991; 19: 35–42.
- Zhang XH, Jin L, Sakamoto H, Takenaka I. Immuno-histochemical localization of metallothionein in human prostate cancer. J Urol 1999; 156: 1679–81.
- Pannek J, Berges RR, Sauvageot J, Lecksell KL, Epstein JI, Partin AW. Cell turnover in human seminal vesicles and the prostate: an immunohistochemical study. Prost Cancer 1999; 2: 200–3.